Mark Pruzanski Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Pruzanski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Pruzanski. Mark Pruzanski is a CEO & President in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and a President & CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a President and CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a See Remarks in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in Equillium, Inc. ($EQ).
Address: C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK 10013 NY
Companies in which Mark Pruzanski is an Insider
Equillium, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Pruzanski: Director
Holdings: 0 shares
Latest Transaction: May 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Pruzanski: Director, See Remarks, CEO & President, President & CEO, President and CEO
Holdings: 506,466 shares
Current Value: $57,519,344
Latest Transaction: May 04 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Pruzanski
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EQ | Equillium, Inc. | Pruzanski Mark | Director | Option Exercise | A | 6.55 | 20,770 | 136,044 | 20,770 | |
| May 04 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 19.78 | 3,817 | 75,500 | 502,649 | 506.5 K to 502.6 K (-0.75 %) |
| May 04 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 19.78 | 6,138 | 121,410 | 506,466 | 500.3 K to 506.5 K (+1.23 %) |
| Apr 01 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 23.08 | 3,658 | 84,427 | 500,328 | 504 K to 500.3 K (-0.73 %) |
| Apr 01 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 23.08 | 6,136 | 141,619 | 503,986 | 497.9 K to 504 K (+1.23 %) |
| Feb 02 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Payment of Exercise | F | 35.24 | 2,741 | 96,593 | 494,453 | 497.2 K to 494.5 K (-0.55 %) |
| Feb 02 2021 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | Director | Grant | A | 35.24 | 6,138 | 216,303 | 497,194 | 491.1 K to 497.2 K (+1.25 %) |